We previously demonstrated that modulation of the VV backbone by deletion of the N1L gene could enhance systemic NK cell responses and prevent postsurgical tumor recurrence in murine models of pancreatic, lung and breast cancer13 and IL-21 is able to increase these responses further. This evidence concerns the gene IL21 and neoplasm.